Evidence map›Paper›PMID 29531105›Full record

ArticleAnnals of family medicine2018

Recent Patterns in Shared Decision Making for Prostate-Specific Antigen Testing in the United States.

Stacey A Fedewa, Ted Gansler, Robert Smith, Ann Goding Sauer, Richard Wender, Otis W Brawley, Ahmedin Jemal

Abstract read
In one paragraph

Article in Annals of family medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Effect of a Prostate Cancer Screening Decision Aid for African-American Men in Primary Care Settings.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Stacey A FedewaIntramural Research Department, American Cancer Society, Atlanta, Georiga stacey.fedewa@cancer.org.
Ted GanslerIntramural Research Department, American Cancer Society, Atlanta, Georiga.
Robert SmithCancer Control Department, American Cancer Society, Atlanta, Georgia.
Ann Goding SauerIntramural Research Department, American Cancer Society, Atlanta, Georiga.
Richard WenderCancer Control Department, American Cancer Society, Atlanta, Georgia.
Otis W BrawleyOffice of the Chief Medical Officer, American Cancer Society, Atlanta, Georgia.
Ahmedin JemalIntramural Research Department, American Cancer Society, Atlanta, Georiga.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePrevious studies report infrequent use of shared decision making for prostate-specific antigen (PSA) testing. It is unknown whether this pattern has changed recently considering increased emphasis on shared decision making in prostate cancer screening recommendations. Thus, the objective of this study is to examine recent changes in shared decision making.

methodsWe conducted a retrospective cross-sectional study among men aged 50 years and older in the United States using 2010 and 2015 National Health Interview Survey (NHIS) data (n = 9,598). Changes in receipt of shared decision making were expressed as adjusted prevalence ratios (aPR) and 95% confidence intervals (CI). Analyses were stratified on PSA testing (recent [in the past year] or no testing). Elements of shared decision making assessed included the patient being informed about the advantages only, advantages and disadvantages, and full shared decision making (advantages, disadvantages, and uncertainties).

resultsAmong men with recent PSA testing, 58.5% and 62.6% reported having received ≥1 element of shared decision making in 2010 and 2015, respectively (

conclusionBetween 2010 and 2015, there was no increase in shared decision making among men with recent PSA testing though there was a shift away from only being told about the advantages of PSA testing towards full shared decision making. Many men receiving PSA testing did not receive shared decision making.

Indexed as

Decision MakingAgedAged, 80 and overCross-Sectional StudiesEarly Detection of CancerHumansLogistic ModelsMaleMass ScreeningMiddle AgedProstate-Specific AntigenProstatic NeoplasmsRetrospective StudiesSurveys and QuestionnairesUnited StatesProstate-Specific Antigendecision makingearly detection of cancerprostate-specific antigen

Identifiers

PMID29531105
PMCPMC5847352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.